anchor-linked platelet inhibitors (RedCell)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameanchor-linked platelet inhibitors (RedCell)
Drug Alias Nameanchor-linked integrin antagonists (RedCell)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell adhesion molecules inhibitors
TargetsCell adhesion molecules
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRedCell Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRedCell Inc
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A